New WHO panel to speed up pandemic response, address shortcomings

Geneva- The World Health Organization‘s governing board agreed on Monday to form a new committee to help speed up its response to health emergencies like COVID-19.

The U.N. health agency faced criticism for its handling of the COVID-19 pandemic, including the pace of its response to early cases that may have delayed detection and helped the virus to spread. Some disease experts say that governments and the WHO must avoid repeating such early missteps with other outbreaks like monkeypox.

The resolution https://apps.who.int/gb/ebwha/pdf_files/EB151/B151_CONF1-en.pdf, passed unanimously at the 34-member Executive Board’s annual meeting, will form a new ‘Standing Committee on Health Emergency Prevention, Preparedness and Response’ to help address some of the perceived shortcomings.

Formal WHO meetings are sometimes spaced months apart and, under the new initiative, the new body would meet immediately after the Director-General declares a Public Health Emergency of International Concern (PHEIC) – a decision that triggers calls for extra funding, public health measures and a series of recommendations aimed at controlling disease spread.

“This was probably one of the weakest points during the last pandemic that member states or governing bodies didn’t have the opportunity to have immediate consultations after this PHEIC of the last pandemic was declared,” Austria’s Clemens Martin Auer, who proposed the resolution, told the Executive Board.

He added that the new committee would also conduct oversight of the WHO’s health emergencies programme in ordinary times to ensure it is fit to respond.

“I think the standing committee will be an indispensable part of the new global architecture on health emergency,” he added. The United States, the European Union, the United Kingdom and Japan were among the co-sponsors of the initiative.

  • Related Posts

    Eli Lilly launches cancer drug Tanstrive in India

    New Delhi: Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from the Central Drugs Standard Control Organisation…

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    The Centre has introduced a risk-based compliance mechanism to ease industry compliance with Quality Control Orders (QCOs), allowing eligible manufacturers to follow a simplified certification route while maintaining product quality…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Eli Lilly launches cancer drug Tanstrive in India

    Eli Lilly launches cancer drug Tanstrive in India

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    India curbs supply of IVF consumables to unregistered clinics

    India curbs supply of IVF consumables to unregistered clinics